NHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
National Health Investors Inc (NHI) is not a strong buy at the moment for a beginner, long-term investor. While the company shows some positive developments like a stable dividend and recent acquisitions, the technical indicators and financial performance suggest a cautious approach. The stock is trading near support levels with no clear bullish momentum, and recent analyst downgrades and mixed financial results further support a hold recommendation.
The MACD histogram is negative and expanding, indicating bearish momentum. The RSI is neutral at 46.704, and the stock is trading near its first support level (S1: 87.586). Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the overall technical setup lacks strong upward momentum.
Recent acquisition of nine senior housing properties for $105.5 million, enhancing market position.
Quarterly dividend of $0.92 per share, providing a stable income stream.
Revenue growth of 23.40% YoY in Q4 2025.
Downgrade by Deutsche Bank to Hold with a price target of $
Decline in net income (-11.69% YoY) and EPS (-15.79% YoY) in Q4
Negative MACD and lack of strong bullish momentum in technical indicators.
In Q4 2025, revenue increased by 23.40% YoY to $105.8 million. However, net income dropped by 11.69% YoY to $38.16 million, and EPS fell by 15.79% YoY to $0.8. Gross margin also declined by 10.35% YoY to 75.43%.
Recent analyst actions include a downgrade by Deutsche Bank to Hold with a price target of $85. Cantor Fitzgerald lowered its price target to $85 but maintained an Overweight rating, citing optimism for 2026. Truist and KeyBanc raised their price targets to $83 and $88, respectively, with positive views on the company's investment opportunities and growth potential.
